Albert Labs International Corp.
ABRT
CNSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.05M | 1.42M | 1.85M | 2.02M | 1.98M |
| Depreciation & Amortization | 12.60K | 9.30K | 7.20K | 2.90K | 5.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.71M | 2.11M | 2.82M | 3.17M | 2.85M |
| Operating Income | -1.71M | -2.11M | -2.82M | -3.17M | -2.85M |
| Income Before Tax | -1.70M | -2.10M | -2.73M | -5.47M | -5.17M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.70 | -2.10 | -2.73 | -5.47 | -5.17 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.70M | -2.10M | -2.73M | -5.47M | -5.17M |
| EBIT | -1.71M | -2.11M | -2.82M | -3.17M | -2.85M |
| EBITDA | -1.70M | -2.10M | -2.81M | -3.16M | -2.84M |
| EPS Basic | -0.04 | -0.04 | -0.05 | -0.11 | -0.11 |
| Normalized Basic EPS | -0.02 | -0.03 | -0.03 | -0.07 | -0.07 |
| EPS Diluted | -0.04 | -0.04 | -0.05 | -0.11 | -0.11 |
| Normalized Diluted EPS | -0.02 | -0.03 | -0.03 | -0.07 | -0.07 |
| Average Basic Shares Outstanding | 260.07M | 253.82M | 247.27M | 225.24M | 222.50M |
| Average Diluted Shares Outstanding | 260.07M | 253.82M | 247.27M | 225.24M | 222.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
